Eugenol introduced directly into the circulatory system of the dog caused a strong but transient reduction in arterial blood pressure and myocardial contractile force, without appreciably changing heart rate or electric activity. Intra-arterial injection of the drug resulted in increased blood flow to the region.
Get full access to this article
View all access options for this article.
References
1.
The United States Pharmacopeia, 17th revision, 1965 , p 250.
2.
Dobbs, E.C.: Pharmacology and Oral Therapeutics, 12th ed, St. Louis: The C. V. Mosby Co., 1961, p 448.
3.
Francis, L.E. and Wood, D.R.: Dental Pharmacology and Therapeutics, Philadelphia : W. B. Saunders Co., 1961, p 53.
4.
Lauber, F.U. and Hollander, F.: Toxicity of the Mucigogue, Eugenol , Administered by Stomach Tube to Dogs, Gastroenterology15:481-486, 1950.
5.
Sober, H.A.; Hollander, F. and Sober, E.K.: Toxicity of Eugenol: Determination of LD50 on Rats, Proc Soc Exp Biol Med73-74:148-151, 1950.
6.
Sober, H.A.; Hollander, F.; and Sonnen-Blick, B.P. : Response of Gastric Mucous Barrier in Pouch Dogs to Repeated Topical Application of Eugenol, Amer J Physiol162:120-130, 1950.
7.
Hollander, F. , and Goldfischer , R.L.: Histological Study of the Destruction and Regeneration of the Gastric Mucous Barrier Following Application of Eugenol. Preliminary Report, J Nat Cancer Inst10:339-346, 1949-1950.
8.
Dundee, J.W. : Clinical Pharmacology of General Anesthetics , Clin Pharmacol Ther8:91-123, 1967.
